Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone furoate with or without desloratadine for moderate-to-severe allergic rhinitis
TCTR20261007012Phase 2Not yet recruiting
- Sponsor
- Vajira Hospital
- Start
- Nov 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluticasone, desloratadine in allergic rhinitis (AR), sponsored by Vajira Hospital. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
fluticasonedesloratadine
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on TCTR20261007012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20261007012.